CAPTRUST Financial Advisors Portfolio holdings
CAPTRUST Financial Advisors is an independent investment advisory firm whose clients include 401(k) plan sponsors, pension funds, endowments, foundations, families and individuals. It was founded in 1997, and Fielding Miller is among its founding partners. From the start the firm has followed a "No-Golf-Ball Rule", under which its advisers may not accept gifts of any kind. In 2002 it also opened up ownership to employees through a broad-based equity model.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$256M |
| 2 |
Broadcom
AVGO
|
+$177M |
| 3 |
NVIDIA
NVDA
|
+$158M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$156M |
| 5 |
Microsoft
MSFT
|
+$114M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$242M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$121M |
| 3 |
ResMed
RMD
|
+$90.9M |
| 4 |
Vanguard International High Dividend Yield ETF
VYMI
|
+$83.3M |
| 5 |
ScottsMiracle-Gro
SMG
|
+$71.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.01% |
| 2 | Technology | 16.85% |
| 3 | Financials | 7.2% |
| 4 | Industrials | 4.88% |
| 5 | Healthcare | 4.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1051
Alnylam Pharmaceuticals
ALNY
$21.4B
| $3.15M | ﹤0.01% |
10,460
-2,043
| -16% | -$616K |
2020 Q2
24 quarters
|
|
1052
Viatris
VTRS
$24.1B
| $3.14M | ﹤0.01% |
197,717
-1,899
| -1% | -$29.4K |
2020 Q2
24 quarters
|
|
1053
Argan
AGX
$4.52B
| $3.14M | ﹤0.01% |
3,927
+33
| +0.8% | +$22K |
2025 Q2
4 quarters
|
|
1054
Ulta Beauty
ULTA
$28.2B
| $3.14M | ﹤0.01% |
6,952
-471
| -6% | -$239K |
2017 Q4
34 quarters
|
|
1055
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.1B
| $3.13M | ﹤0.01% |
46,524
+982
| +2% | +$65.6K |
2023 Q2
12 quarters
|
|
1056
Ameren
AEE
$31.4B
| $3.13M | ﹤0.01% |
27,662
+1,282
| +5% | +$142K |
2018 Q2
32 quarters
|
|
1057
Tyler Technologies
TYL
$16.9B
| $3.12M | ﹤0.01% |
10,680
-969
| -8% | -$306K |
2017 Q4
34 quarters
|
|
1058
LKQ Corp
LKQ
$5.05B
| $3.12M | ﹤0.01% |
118,428
+822
| +0.7% | +$22.8K |
2020 Q1
25 quarters
|
|
1059
iShares Core Universal USD Bond ETF
IUSB
$50.1B
| $3.11M | ﹤0.01% |
67,296
+12,475
| +23% | +$575K |
2019 Q4
26 quarters
|
|
1060
Roblox
RBLX
$37.7B
| $3.1M | ﹤0.01% |
57,081
+14,196
| +33% | +$706K |
2024 Q3
7 quarters
|
|
1061
Omega Healthcare
OHI
$14.6B
| $3.09M | ﹤0.01% |
64,891
-4,380
| -6% | -$203K |
2022 Q3
15 quarters
|
|
1062
Old National Bancorp
ONB
$9.6B
| $3.08M | ﹤0.01% |
118,789
+11,791
| +11% | +$283K |
2023 Q4
10 quarters
|
|
1063
Suncoast Select Growth ETF
SEMG
$62.4M
| $3.07M | ﹤0.01% |
+115,941
| New | +$3.03M |
2026 Q2
0 quarters
|
|
1064
Aramark
ARMK
$14.2B
| $3.07M | ﹤0.01% |
54,000
+1,438
| +3% | +$71K |
2020 Q2
24 quarters
|
|
1065
InterContinental Hotels
IHG
$26.4B
| $3.07M | ﹤0.01% |
17,748
+33
| +0.2% | +$5.05K |
2025 Q1
5 quarters
|
|
1066
TIM SA
TIMB
$9.28B
| $3.07M | ﹤0.01% |
143,257
-2,284
| -2% | -$54.4K |
2026 Q1
1 quarter
|
|
1067
Capital Group Ultra Short Income ETF
CGUI
$389M
| $3.06M | ﹤0.01% |
121,214
+16,006
| +15% | +$405K |
2024 Q4
6 quarters
|
|
1068
GE HealthCare
GEHC
$37.3B
| $3.06M | ﹤0.01% |
47,861
-3,230
| -6% | -$212K |
2023 Q1
13 quarters
|
|
1069
Sunoco
SUN
$12.3B
| $3.06M | ﹤0.01% |
45,344
+984
| +2% | +$65.4K |
2024 Q2
8 quarters
|
|
1070
Invesco
IVZ
$12.6B
| $3.06M | ﹤0.01% |
115,897
+19,356
| +20% | +$513K |
2020 Q2
24 quarters
|
|
1071
Revolution Medicines
RVMD
$39.1B
| $3.05M | ﹤0.01% |
16,289
+5,851
| +56% | +$855K |
2024 Q1
9 quarters
|
|
1072
Trimble
TRMB
$12.9B
| $3.05M | ﹤0.01% |
59,562
-24,642
| -29% | -$1.46M |
2017 Q4
34 quarters
|
|
1073
Invesco NASDAQ 100 ETF
QQQM
$107B
| $3.04M | ﹤0.01% |
10,023
+1,394
| +16% | +$395K |
2023 Q4
10 quarters
|
|
1074
MKS Inc
MKSI
$15.3B
| $3.03M | ﹤0.01% |
6,821
+1,176
| +21% | +$368K |
2020 Q2
24 quarters
|
|
1075
HBT Financial
HBT
$1.35B
| $3.03M | ﹤0.01% |
94,743
-448
| -0.5% | -$12.9K |
2025 Q1
5 quarters
|
|
Similar funds
CAPTRUST Financial Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, CAPTRUST Financial Advisors held 3,427 positions worth $65.5B, up 14% from $57.3B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
CAPTRUST Financial Advisors deployed $2.07B of net new capital in Q2 2026, opening 411 new positions and adding to 1,662 existing holdings. Its largest new stake was Honeywell Aerospace: 167,752 shares worth $37.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 52% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $121M trimmed.
- CAPTRUST Financial Advisors's largest Q2 2026 buy was Honeywell Aerospace: 167,752 shares worth $37.1M.
- CAPTRUST Financial Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $256M increase.
- CAPTRUST Financial Advisors's biggest Q2 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $121M.
- CAPTRUST Financial Advisors fully exited ExxonMobil in Q2 2026, selling an estimated $242M.
- CAPTRUST Financial Advisors's ten largest holdings make up 27% of its $65.5B portfolio in Q2 2026.
- CAPTRUST Financial Advisors opened 411 new positions and closed 153 in Q2 2026.
- CAPTRUST Financial Advisors's portfolio value rose 14% quarter-over-quarter to $65.5B.
Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.